trial
as of 2026-07-01Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
NCTId NCT00864825
at a glance
Phase 4 · Completed
Enrollment 248 (actual)
Sponsored by Sheba Medical Center
Primary completion 2009-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
248 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2009-08
Primary completion
2009-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Sheba Medical CenterLead Sponsor
Investigators
1
Mark Weiser, MDPrincipal Investigator
Sites
33 total
Bat Yam, IsraelBeer-Yaakov, IsraelHod HaSharon, IsraelJaffa, IsraelJerusalem, IsraelJerusalem, IsraelNess Ziona, IsraelShaar Menashe, IsraelTel Hashomer, Ramat Gan, IsraelTsur Moshe, IsraelBd. Iosif Bulbuca, 156, Jud Timis, RomaniaBerceni St., 10-12, Bucharest, Romania
Facts & assertions
4 sourced
Enrollment
248
Phase
PHASE4
Primary Completion Date
2009-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person